从悦心健康十大流通股东角度 数据显示，国泰基金旗下1只基金位居悦心健康十大流通股东。国泰中证全指建筑材料ETF（159745） 三季度新进十大流通股东，持有股数196.29万股，占流通股的比例为0.21%。根据测算，今日浮盈赚取 约49.07万元。 国泰中证全指建筑材料ETF（159745）成立日期2021年6月9日，最新规模11.02亿。今年以来收益 12.31%，同类排名3308/4197；近一年收益8.65%，同类排名3446/4170；成立以来亏损34.58%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 12月25日，悦心健康涨5.33%，截至发稿，报4.94元/股，成交1.40亿元，换手率3.16%，总市值45.43亿 元。 责任编辑：小浪快报 资料显示，上海悦心健康集团股份有限公司位于上海市闵行区浦江镇恒南路1288号，成立日期1993年6 月8日，上市日期2007年8月23日，公司主营业务涉及经营高端建筑陶瓷品牌"斯米克"瓷砖和生态功能性 建材产品"斯 ...

12月18日，悦心健康涨5.76%，截至发稿，报4.77元/股，成交2.00亿元，换手率4.71%，总市值43.87亿 元。 资料显示，上海悦心健康集团股份有限公司位于上海市闵行区浦江镇恒南路1288号，成立日期1993年6 月8日，上市日期2007年8月23日，公司主营业务涉及经营高端建筑陶瓷品牌"斯米克"瓷砖和生态功能性 建材产品"斯米克负离子健康材料";主打"悦心健康"品牌,聚焦在综合医院、妇产生殖及口腔领域;养老服 务业务;投资性房地产租赁。主营业务收入构成为：瓷砖-大理石35.96%，瓷砖-仿古砖31.86%，大健康 (康养/医疗/职业教育)11.19%，仓库租赁等8.71%，瓷砖-瓷片6.71%，瓷砖-玻化石5.09%，瓷砖-其他 0.48%。 从悦心健康十大流通股东角度 数据显示，国泰基金旗下1只基金位居悦心健康十大流通股东。国泰中证全指建筑材料ETF（159745） 三季度新进十大流通股东，持有股数196.29万股，占流通股的比例为0.21%。根据测算，今日浮盈赚取 约51.03万元。 国泰中证全指建筑材料ETF（159745）成立日期2021年6月9日，最新规模11.02亿。今年以来收益 1 ...

Core Viewpoint - The stock of Yueshen Health has shown significant growth this year, with a 49.13% increase, and recent trading activity indicates strong investor interest [1][2]. Group 1: Stock Performance - As of December 3, Yueshen Health's stock price increased by 2.38% to 5.16 CNY per share, with a trading volume of 1.81 billion CNY and a turnover rate of 3.91%, resulting in a total market capitalization of 47.46 billion CNY [1]. - Year-to-date, Yueshen Health's stock has risen by 49.13%, with a 6.83% increase over the last five trading days, 14.16% over the last 20 days, and 15.70% over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" five times this year, with the most recent appearance on March 19, where it recorded a net buy of -11.8465 million CNY [1]. Group 2: Company Overview - Yueshen Health, established on June 8, 1993, and listed on August 23, 2007, is based in Shanghai and focuses on high-end building ceramics and health-related materials [2]. - The company's main revenue sources include: 35.96% from marble tiles, 31.86% from antique tiles, 11.19% from health services, and smaller percentages from other products [2]. - As of November 30, the number of shareholders stood at 54,800, with an average of 16,763 circulating shares per person [2]. Group 3: Financial Performance - For the period from January to September 2025, Yueshen Health reported a revenue of 771 million CNY, a year-on-year decrease of 13.23%, while the net profit attributable to shareholders was 3.0843 million CNY, reflecting a year-on-year increase of 109.33% [2]. - The company has distributed a total of 89.3 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]. - As of September 30, 2025, the top ten circulating shareholders included the Guotai Zhongzheng All-Index Building Materials ETF, which holds 1.9629 million shares as a new shareholder [3].

Group 1 - The core viewpoint of the news is that Yuexin Health has seen a stock price increase of 5.01%, reaching 5.24 CNY per share, with a trading volume of 1.23 billion CNY and a turnover rate of 2.63%, resulting in a total market capitalization of 48.19 billion CNY [1] - Yuexin Health, established on June 8, 1993, and listed on August 23, 2007, operates in high-end building ceramics and health-related materials, focusing on comprehensive hospitals, reproductive health, and elderly care services [1] - The revenue composition of Yuexin Health includes: 35.96% from marble tiles, 31.86% from antique tiles, 11.19% from health services, 8.71% from warehouse leasing, 6.71% from ceramic tiles, 5.09% from glass tiles, and 0.48% from other tile products [1] Group 2 - Among the top ten circulating shareholders of Yuexin Health, Guotai Fund's ETF has entered the list, holding 1.9629 million shares, which is 0.21% of the circulating shares, with an estimated profit of approximately 490,700 CNY [2] - The Guotai CSI All-Index Building Materials ETF was established on June 9, 2021, with a current scale of 1.102 billion CNY, yielding 13.06% this year, ranking 3285 out of 4206 in its category [2] - The fund manager of the Guotai CSI All-Index Building Materials ETF is Huang Yue, who has been in the position for 4 years and 302 days, with a total asset scale of 35.78 billion CNY [3]

Core Points - Yueshen Health's stock price increased by 6% on November 27, reaching 5.12 CNY per share, with a trading volume of 251 million CNY and a turnover rate of 5.59%, resulting in a total market capitalization of 4.709 billion CNY [1] - The stock has seen a cumulative increase of 4.77% over the past three days [1] Company Overview - Shanghai Yueshen Health Group Co., Ltd. was established on June 8, 1993, and went public on August 23, 2007 [1] - The company specializes in high-end building ceramics under the "Simik" brand and ecological functional building materials, focusing on comprehensive hospitals, reproductive health, oral care, elderly services, and investment real estate leasing [1] - Revenue composition includes: - Marble tiles: 35.96% - Antique tiles: 31.86% - Health services (wellness/medical/vocational education): 11.19% - Warehouse leasing: 8.71% - Ceramic tiles: 6.71% - Glass-ceramic tiles: 5.09% - Other tiles: 0.48% [1] Shareholder Insights - Guotai Fund's ETF, Guotai Zhongzheng All Index Building Materials ETF (159745), entered the top ten circulating shareholders in Q3, holding 1.9629 million shares, representing 0.21% of circulating shares [2] - The ETF has generated a floating profit of approximately 569,200 CNY today and 431,800 CNY during the three-day increase [2] - The ETF was established on June 9, 2021, with a current size of 1.102 billion CNY, yielding 11.07% year-to-date and 7.65% over the past year [2]

Group 1 - The core viewpoint of the news is that Yueshen Health's stock has increased by 5.7%, reaching 5.01 CNY per share, with a trading volume of 1.29 billion CNY and a market capitalization of 4.608 billion CNY [1] - Yueshen Health, established on June 8, 1993, and listed on August 23, 2007, operates in high-end building ceramics and health-related materials, focusing on comprehensive hospitals, reproductive health, and elderly care services [1] - The company's main revenue sources include: 35.96% from marble tiles, 31.86% from antique tiles, 11.19% from health services, 8.71% from warehouse leasing, 6.71% from ceramic tiles, 5.09% from glass tiles, and 0.48% from other tile products [1] Group 2 - Among Yueshen Health's top ten circulating shareholders, Guotai Fund's ETF has entered the list, holding 1.9629 million shares, which is 0.21% of the circulating shares, with an estimated profit of approximately 530,000 CNY [2] - The Guotai CSI All-Index Building Materials ETF was established on June 9, 2021, with a current size of 1.102 billion CNY, yielding 11.52% this year and 7.89% over the past year [2] - The fund manager, Huang Yue, has been in position for 4 years and 296 days, managing assets totaling 35.78 billion CNY, with the best return of 45.68% and the worst return of -60.02% during his tenure [3]

Core Viewpoint - The stock price of Yueshen Health has shown significant growth this year, with a year-to-date increase of 41.04%, indicating strong market interest and potential investment opportunities [1][2]. Company Overview - Yueshen Health Group, established on June 8, 1993, and listed on August 23, 2007, is based in Shanghai and primarily operates in high-end ceramic tiles and health-related materials [2]. - The company's main revenue sources include: - Marble tiles: 35.96% - Antique tiles: 31.86% - Health services (wellness/medical/professional education): 11.19% - Warehouse leasing: 8.71% - Other tile products: 13.28% combined [2]. Financial Performance - For the period from January to September 2025, Yueshen Health reported a revenue of 771 million yuan, a year-on-year decrease of 13.23%, while the net profit attributable to shareholders was 3.08 million yuan, reflecting a year-on-year increase of 109.33% [2]. - The company has distributed a total of 89.3 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Market Activity - As of November 12, Yueshen Health's stock price was 4.88 yuan per share, with a trading volume of 31.76 million yuan and a market capitalization of 4.488 billion yuan [1]. - The stock has appeared on the "Dragon and Tiger List" five times this year, indicating notable trading activity [1].

Core Viewpoint - Shanghai Yueshen Health Group plans to use surplus reserves of 72.85 million yuan and capital reserves of 141 million yuan, totaling 214 million yuan, to offset cumulative losses, resulting in a significant reduction of its reserves and a nearly 400% drop in net profit for 2024 [1][2][4]. Financial Summary - For 2024, the company reported revenue of 1.204 billion yuan, a year-on-year decrease of 5.79%, and a net profit attributable to shareholders of -147 million yuan, a staggering decline of 393.87% [4]. - The company has experienced negative net profits for three consecutive years, with cumulative losses exceeding 500 million yuan, indicating concerns over its core business's ability to generate profits [4]. - The company's operating cash flow also decreased by 33.48% year-on-year, amounting to 82.23 million yuan [4]. Business Transformation - Yueshen Health, originally focused on ceramic tiles, has been transitioning into the health sector since 2015, with its business now encompassing building materials, health services, and investment property leasing [5]. - The company’s building materials segment primarily focuses on high-end ceramic tile brand "Simik," while its health services include various care systems and training programs [5]. Loss Factors - The primary reasons for the company's losses include a decline in revenue from the ceramic tile business due to reduced market demand, increased competition, and rising costs [3]. - The company has also faced challenges related to the long investment cycle of its health projects and asset impairment losses, which have further exacerbated its financial difficulties [4].

上海悦心健康集团股份有限公司 2024 年年度报告全文 上海悦心健康集团股份有限公司 2024 年年度报告 2025 年 2 月 28 日 1 上海悦心健康集团股份有限公司 2024 年年度报告全文 2024 年年度报告 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别 和连带的法律责任。 公司负责人李慈雄、主管会计工作负责人赵一非及会计机构负责人（会 计主管人员）刘晓青声明：保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 有关公司经营风险及应对措施，请参见本报告"第三节 管理层讨论与分 析" 中"十一、公司未来发展的展望"之"（三）可能面对的风险"的相关 具体内容陈述。 公司经本次董事会审议通过的利润分配预案为：以 921,584,303 为基数， 向全体股东每 10 股派发现金红利 0 元（含税），送红股 0 股（含税），不以公 积金转增股本。 2 | 目录 | | --- | | 第一节 重要提示、目录和释义 2 | | | --- | --- | | ...